« Return to News | R&D Trends | CROs/Service Providers

GVK partners with Gates Foundation

Monday, May 16, 2011 12:44 PM

India-based CRO GVK Biosciences has been named as a preferred provider by a consortium, Product Development Partners (PDP), which is focused on drugs for neglected diseases.

Under the terms of the agreement, GVK will provide clinical support, logistics, monitoring and project management for trials PDP is conducting in India and Bangladesh.  PDP is a group of non-profit entities partially funded by the Bill and Melinda Gates Foundation.

PDP’s target illnesses include tuberculosis, malaria, HIV, pneumonia and diarrhea which, despite affecting millions of people, are often overlooked by drug companies in favor of conditions that can generate more income. 

Shoibal Mukherjee, senior vice president of clinical development at GVK, said, “GVK Biosciences has been working in the area of neglected diseases for several years, and it is this experience that puts the company in a position to participate in the Global Health Product Development Partners Consortium.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.